Centers for Disease Control and Prevention.Diabetes: Disabling, Deadly, and on the Rise. Atlanta, GA: US Department Of Health and Human Services; 2004.
2.
Mokdad AH, Bowman BA, Ford ES, Vinicor F., Marks JS, Koplan JPThe continuing epidemics of obesity and diabetes in the United States . JAMA. 2001;286:1195-2000.
3.
Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults.The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998;21:518-524.
4.
Centers for Disease Control and Prevention.National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2003.pdf. Accessed March 31, 2009.
5.
American Diabetes Association.National Diabetes Fact Sheet 2004. http://www./cdc/gov/diabetes/pubs/pdf/ndfs_2003.pdf . Accessed March 31, 2009.
6.
Meigs JB, Wilson PW, Nathan DM, D’Agostino RB, Williams K., Haffner SMPrevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003;52:2160-2167.
7.
Lu W., Resnick HE, Jain AK, et al. Effects of isolated postchallenge hyperglycemia on mortality in American Indians: the Strong Heart Study. Ann Epidemiol . 2003;13:182-188.
8.
Gerstein HC, Santaguida P., Raina P., et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract. 2007;78:305-312.
9.
UK Prospective Diabetes Study (UKPDS) Group.Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
Gilies CL, Abrams KR, Lambert PC, et al. Pharmacologic and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta analysis. BMJ. 2007;334:299.
12.
Knowler WC, Barrett-Connor E., Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 ;346:393-403.
13.
The Diabetes Prevention Program Research Group.The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25:2165-2171.
14.
The Diabetes Prevention Program Research Group.The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci. 2006;61: 1075-1081.
15.
The Diabetes Prevention Program Research Group.Achieving weight and activity goals among Diabetes Prevention Program lifestyle participants. Obes Res. 2004;12:1426-1434.
16.
Herman WH, Hoerger TJ, Brandle M., et al, for the Diabetes Prevention Program Research Group.The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med. 2005;142:323-332.
17.
The Diabetes Prevention Program Research Group.Costs associated with the primary prevention of type 2 diabetes mellitus in the Diabetes Prevention Program. Diabetes Care. 2003;26:36-47.
18.
Hamman RF, Wing RR, Edelstein SL, et al, for the Diabetes Prevention Program Research Group.Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29:2102-2107.
